Blood Transfusion Strategies in Patients Undergoing Extracorporeal Membrane Oxygenation.
10.4266/kjccm.2016.00983
- Author:
Hyoung Soo KIM
;
Sunghoon PARK
- Publication Type:Review
- Keywords:
blood transfusion;
extracorporeal membrane oxygenation
- MeSH:
Adult;
Blood Transfusion*;
Child;
Critical Illness;
Erythrocytes;
Extracorporeal Membrane Oxygenation*;
Heart Failure;
Hemorrhage;
Hospital Costs;
Humans;
Infant, Newborn;
Mortality;
Platelet Transfusion;
Respiratory Insufficiency
- From:Korean Journal of Critical Care Medicine
2017;32(1):22-28
- CountryRepublic of Korea
- Language:English
-
Abstract:
Extracorporeal membrane oxygenation (ECMO) is frequently associated with bleeding and coagulopathy complications, which may lead to the need for transfusion of multiple blood products. However, blood transfusions are known to increase morbidity and mortality, as well as hospital cost, in critically ill patients. In current practice, patients on ECMO receive a transfusion, on average, of 1-5 packed red blood cells (RBCs)/day, with platelet transfusion accounting for the largest portion of transfusion volume. Generally, adult patients require more transfusions than neonates or children, and patients receiving venovenous ECMO for respiratory failure tend to need smaller transfusion volumes compared to those receiving venoarterial ECMO for cardiac failure. Observation studies have reported that a higher transfusion volume was associated with increased mortality. To date, the evidence for transfusion in patients undergoing ECMO is limited; most knowledge on transfusion strategies was extrapolated from studies in critically ill patients. However, current data support a restrictive blood transfusion strategy for ECMO patients, and a low transfusion trigger seems to be safe and reasonable.
